(MedPage Today) — NEW ORLEANS — IV tenecteplase (TNKase) could be beneficial as far out as 24 hours after stroke onset in people not getting mechanical thrombectomy, the OPTION trial showed.
In people with acute non-large vessel occlusion…
Source link : https://www.medpagetoday.com/meetingcoverage/isc/119777
Author :
Publish date : 2026-02-06 19:43:00
Copyright for syndicated content belongs to the linked Source.
